Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if ...

During a live event, Mark J. Fesler, MD, and participants discuss next steps for a 68-year-old patient with intermediate-risk ...

The risk of cancer goes up with age, in part because aging impedes the body's ability to detect and destroy cells with ...

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

Stem cells are often described as the body's master cells. Healthy stem cells can restore the blood system after cancer ...

The Boao Lecheng International Medical Tourism Pilot Zone in Hainan province has released pricing for China's first batch of ...

Researchers sought to determine whether MSD HSCT or auto-HSCT would have advantages over chemotherapy in post-remission treatment for patients with AML.

Now, Kaufman, a 20-year-old sophomore baseball player and business finance major at Roanoke College, is facing his toughest ...

A woman is attempting to break a world record for running the London Marathon dressed as a blood stem cell. Louise Cato from ...

In a first-of-its-kind human trial, researchers transplanted iPS-cell-derived dopaminergic progenitors into patients with ...

Two small clinical trials tested the safety of injecting stem cells into the brains of Parkinson's patients and found no ...

Autologous mononuclear cells showed substantial activity in patients with advanced heart failure — and even though the study ...